A technique developed by University of Texas at Dallas and UT Southwestern Medical Center researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, the most common human brain cancer.
Click here for original story, Drug-delivery technique with vessel-targeted gold nanoparticles shows growing promise for brain cancer treatment
Source: Phys.org